Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-13-018646

Chief Financial Officer acquired 6,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Greene Rick Scott Chief Financial Officer 2013-03-26 Grant or award +6,000 $4.78 $28,680 39,000 D
Loading xslF345X03/doc4.xml…